NCT06261931Not yet recruiting
Severity Over Time of Early Forms of Spondyloarthritis
Severity Over Time of Early Forms of Spondyloarthritis, a Prospective Observational Study.
Source: ClinicalTrials.gov · Last updated 15 Feb 2024 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
Spondyloarthritis (SpA) is a group of chronic inflammatory pathologies whose progression over time is poorly defined, and in particular the clinical and instrumental elements that can predispose to a condition of disease severity are not completely known. It would be important to have an idea of what the predisposing factors are, possibly already at baseline, and possibly also at follow up, of severe disease, so as to be able to act early with more aggressive and targeted therapies on these patients, so as to achieve remission.
- Status (registry)
- Not yet recruiting
- Study type
- Observational
- Enrollment
- 387 (estimated)
- First submitted
- 8 Feb 2024
- Start date
- 12 Feb 2024
- Primary completion date
- 28 Feb 2026
- Lead sponsor
- Fondazione Policlinico Universitario Agostino Gemelli IRCCS
- NCT number
- NCT06261931
What you commit to
- Study type: Observational
- Planned participants: 387
- From 12 Feb 2024 to the primary completion date, 28 Feb 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Patients suffering from other rheumatic pathologies (even in overlap), or genetic diseases such as Marfan syndrome, Ehlers Danlos syndrome
- Any medical or psychiatric condition that in the judgment of the investigator would prevent the participant from complying with the protocol or completing the study according to the protocol.
Age
- Age \< 18 years;
Other
- Refusal to sign the informed consent to the study.
Who the study is looking for
- age \>18 years;
- Diagnosis of SpA confirmed by the rheumatologist with duration of symptoms \<
- 2 years;
- Signature of the written informed consent to the study
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Fondazione Policlinico Universitario A. Gemelli IRCCS Coordinator of this site? Confirm its status | Roma | Italy | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.